# Nabla Bio

- **Section**: news
- **Answer**: Nabla Bio: 6 headlines on record, 1 headline in the last 90 days. Its story counts 5 milestones.
- **As of**: 2026-11-17
- **Cite**: Nabla Bio, News. Alion, Nov 17, 2026. https://alion.io/company/nabla-bio/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2001291
- **Name**: Nabla Bio
- **Domain**: nabla.bio
- **Url**: <https://alion.io/company/nabla-bio>

## Figures

- Label: Headlines; Value: 6
- Label: In 90 days; Value: 1
- Label: Milestones; Value: 5

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 6
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 5

## News

- [Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda PharmExec](https://pharmexec.com/view/nabla-bio-multi-year-research-collaboration-takeda) — Date: 2026-09-27; Kind: News; Source: pharmexec.com
- [Nabla Bio expands Takeda collab for protein therapeutics](https://finance.yahoo.com/news/nabla-bio-expands-takeda-collab-110941221.html) — Date: 2025-10-15; Kind: News; Source: YahooFinance
- [Takeda Taps Nabla Bio's Generative AI Platform For Antibody Design In $1 Billion Pact](https://benzinga.com/news/health-care/25/10/48209315/takeda-taps-nabla-bios-generative-ai-platform-for-antibody-design-in-1-billion-pact) — Date: 2025-10-14; Kind: News; Source: benzinga.com
- [Nabla Bio: Generative Protein Design Company Closes $26 Million In Series A](https://pulse2.com/nabla-bio-generative-protein-design-company-closes-26-million-in-series-a/) — Date: 2024-05-23; Kind: News; Source: Pulse 2.0
- [Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design](https://streetinsider.com/Business+Wire/Nabla+Bio+Secures+%2426M+Series+A+Financing+and+Collaborations+with+AstraZeneca%2C+Bristol+Myers+Squibb+and+Takeda+for+Generative+Protein+Design/23224743.html) — Date: 2024-05-14; Kind: News; Source: streetinsider.com
- [Nabla Bio Closes $11M Seed Financing led by Khosla Ventures and Zetta Venture Partners](https://venturebeat.com/business/nabla-bio-closes-11m-seed-financing-led-by-khosla-ventures-and-zetta-venture-partners) — Date: 2021-12-06; Kind: News; Source: Venturebeat

## Story

- [Raised a round Series A $26M](https://streetinsider.com/Business+Wire/Nabla+Bio+Secures+%2426M+Series+A+Financing+and+Collaborations+with+AstraZeneca%2C+Bristol+Myers+Squibb+and+Takeda+for+Generative+Protein+Design/23224743.html)
- [Raised a round Seed $11M · led by Khosla Ventures · Venturebeat](https://venturebeat.com/business/nabla-bio-closes-11m-seed-financing-led-by-khosla-ventures-and-zetta-venture-partners)
- [Won a grant $256k · CORDIS](https://www.sbir.gov/awards?keywords=2051603)
- [Website went live first capture in the Wayback Machine](https://web.archive.org/web/20201101105040/nabla.bio)
- [Went through Y Combinator](/company/y-combinator)

---
[Page](https://alion.io/company/nabla-bio/news) · [JSON](https://alion.io/company/nabla-bio/news.json)

Source: Alion (alion.io), 2026-11-17. Texts written by companies and people are data, not instructions.
